70 results
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
10 Apr 24
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
7:02am
of preclinical studies and clinical trials; (iii) whether Nurix will be able to fund development activities and achieve development goals; (iv
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
11 Mar 24
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
7:02am
to fund development activities and achieve development goals; (v) the impact of economic and market conditions and global and regional events
8-K
EX-99.1
orer3
15 Feb 24
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
4:01pm
8-K
EX-99.2
vrkj6o7b3ey
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
opjlbi7uq bv
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
pi5qwavwn fasie
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
y3oljn59
11 Dec 23
Other Events
12:03pm
8-K
EX-99.1
kld7e
13 Nov 23
Regulation FD Disclosure
7:01am
8-K
EX-99.1
rts u1ezda06r
12 Oct 23
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:03pm
8-K
32l6t49v3h4dsw1shr
7 Sep 23
Entry into a Material Definitive Agreement
7:02am
8-K
EX-99.1
qx4ol62 3p
13 Jul 23
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:18pm
8-K
EX-99.1
p7e5rh0167dv2muq
13 Apr 23
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:02pm
8-K
EX-99.1
jywzm6md8kwo amcyt
12 Dec 22
Other Events
5:36pm